Back

Treatment patterns and adherence to lipid-lowering drugs during 8 years of follow-up after a cardiovascular event

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Risk factors and prevention: lipids (1) Drug therapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Ms Ingrid Engebretsen

Oslo Economics, Oslo (Norway)

7 More presentations in this session

Presentation thumbnail
Severe hypertriglyceridemia and its correlation with clinical atherosclerosis and pancreatitis investigated in beta-quantification
Associate Professor Y. Winhofer (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Comparison of estimated LDL cholesterol equations with direct measurement
Mr G. Velisaris (Athens, GR)
Abstract Slides Video
Presentation thumbnail
The Cycle study: a prospective study on cholesterol levels during the menstrual cycle
Miss J. Mulder (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Low-density lipoprotein cholesterol reduction and short-term incidence of ASCVD in the population-based cohort study LATINO
Professor C. Gavina (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Association of statin use and outcomes in elderly with multiple risk factors: insight from the CORE registry Thailand.
Doctor P. Chichareon (Hat Yai, TH)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors and prevention: lipids (1)

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Lipid control in cardiovascular patients
thumbnail
Congress Presentation
Fix the plaque, fight the lipids: why low-density lipoproteins still matter after percutaneous coronary intervention
thumbnail
Congress Presentation
What’s new in LDL lowering?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources